2026-01-26 - Analysis Report
**Company Overview:** C.H. Robinson is a third-party logistics (3PL) and transportation company that provides a range of supply chain services to customers in various industries.

**Return Rate Comparison:**
* Rate of CHRW: 130.19%
* Rate of VOO (S&P 500): 126.41%
* Divergence: 3.40, Relative Divergence: 87.00%
The cumulative return of CHRW is higher than that of VOO, indicating a divergence of 3.40 percentage points. This is a relatively high divergence compared to the minimum-maximum fluctuation range.

**Alpha, Beta Analysis:**
| Year | CAGR | MDD | Alpha | Beta | Cap(B) |
|------|------|------|-------|------|-------|
| 2016-2018 | 13.0% | 14.5% | 1.0% | 0.7 | 9.9B |
| 2017-2019 | -4.0% | 16.4% | -29.0% | 0.8 | 9.2B |
| 2018-2020 | -3.0% | 25.8% | -27.0% | 0.6 | 11.1B |
| 2019-2021 | 26.0% | 25.8% | -39.0% | 0.6 | 12.7B |
| 2020-2022 | 22.0% | 23.6% | 15.0% | 0.6 | 10.8B |
| 2021-2023 | -3.0% | 23.6% | -23.0% | 0.7 | 10.2B |
| 2022-2024 | -2.0% | 28.4% | -32.0% | 0.6 | 12.2B |
| 2023-2025 | 80.0% | 26.0% | 5.0% | 0.7 | 19.0B |
CHRW has had varying CAGR and MDD (Maximum Drawdown) over different periods, with the most recent period (2023-2025) showing a CAGR of 80.0% and a MDD of 26.0%.

**Recent Stock Price Fluctuations:**
* Close: $176.66
* Last-market: $176.66 ( change: -0.7)
* 5-day SMA: $176.96
* 20-day SMA: $169.84
* 60-day SMA: $159.65
CHRW's stock price has been relatively stable, with a slight decline in the last market.

**RSI, PPO Index Indicators and Other Analysis:**
* Market Risk Indicator (MRI): 0.70 (Risk level: Medium)
* RSI: 75.63
* PPO: 0.20
* Hybrid Signal: Buy (Cash 0%)
Risk Level: Medium (MRI 0.70)
Recent (20 days) relative divergence change: +2.50 (improving)
7-day Rank change: 0 (flat)
7-day Dynamic Expected Return change: 0.00 (flat)
Expected Return (%): -16.60%
CHRW's RSI is high, indicating overbought conditions. However, the PPO is low, suggesting a potential buy signal.

**Recent News & Significant Events:**
The headlines from Yahoo Finance indicate that CHRW has had recent share price momentum, with some analysts recommending a buy.

**Analyst Opinions:**
Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 2.04 (~Buy)
- Opinions: 25
- Target Price (avg/high/low): 173.28 / 224.00 / 85.00
Analysts are generally bullish on CHRW, recommending a buy with an average target price of $173.28.

**Recent Earnings Analysis:**
| Date | EPS | Revenue |
|-----|-----|---------|
| 2025-10-31 | 1.36 | $4.14B |
| 2025-08-01 | 1.27 | $4.14B |
| 2025-05-02 | 1.12 | $4.05B |
| 2024-11-01 | 0.81 | $4.64B |
| 2025-10-31 | 0.81 | $4.64B |
EPS has been relatively stable, with revenue fluctuating between $4.05B and $4.64B.

**Financial Information:**
### Revenue and Profitability:
| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $4.14B | 8.62% |
| 2025-06-30 | $4.14B | 8.65% |
| 2025-03-31 | $4.05B | 8.02% |
| 2024-12-31 | $4.18B | 7.89% |
| 2024-09-30 | $4.64B | 8.05% |
Revenue has been relatively stable, with profit margin fluctuating between 7.89% and 8.65%.

### Capital and Profitability:
| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $1.86B | 8.78% |
| 2025-06-30 | $1.78B | 8.54% |
| 2025-03-31 | $1.73B | 7.80% |
| 2024-12-31 | $1.72B | 8.67% |
| 2024-09-30 | $1.64B | 5.93% |
Equity has been steadily increasing, with ROE fluctuating between 5.93% and 8.78%.

**Comprehensive Analysis:**
* CHRW has a higher cumulative return rate compared to VOO (S&P 500)
* Recent Alpha and Beta analysis indicates varying performance over different periods
* RSI is high, indicating overbought conditions, but PPO suggests a potential buy signal
* Recent news headlines indicate recent share price momentum
* Analyst consensus recommends a buy with an average target price of $173.28
* EPS and revenue have been relatively stable, with fluctuating profit margin and ROE.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.